Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
48.03
-1.40 (-2.83%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $2.31 billion as of March 23, 2026. Its market cap has increased by 350.08% in one year.
Market Cap
2.31B
Enterprise Value
1.95B
1-Year Change
350.08%
Ranking
Category
Stock Price
$48.03
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $2.31B, an increase of 237.28%. That is a compound annual growth rate of 192.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.31B | 15.93% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.51B |
| Travere Therapeutics | 2.48B |
| Immunome | 2.26B |
| Disc Medicine | 2.22B |
| Day One Biopharmaceuticals | 2.21B |
| Wave Life Sciences | 2.21B |
| Apellis Pharmaceuticals | 2.20B |
| Veradermics | 2.20B |